The LAL assay is a standard method for endotoxin detection of medical devices and parenteral drugs.
Learn More →Creative Biolabs delivers end-to-end pyrogen testing solutions, ensuring your parenteral drugs, biologics, and medical devices meet stringent endotoxin limit (EL) requirements mandated by global health authorities. Customers receive a robust, product-specific testing protocol developed by our experts to overcome known challenges like matrix effects and the critical problem of endotoxin masking. Our core problem-solving capability is providing definitive, audit-ready data packages using the most scientifically appropriate assay (LAL, rFC, or MAT) to guarantee product safety and streamline your path to market. We prioritize method validity over speed to ensure total compliance.
Endotoxin detection is mandated for all injectable products, focusing on lipopolysaccharide (LPS), a potent bacterial pyrogen that causes fever and septic shock, with detection methods targeting the lipid A moiety. Current research underscores that the non-specific binding of LPS to therapeutic proteins (masking) poses a significant challenge, frequently leading to false negative results. Accurate testing requires specialized sample preparation to break these molecular interactions. Understanding this masking phenomenon is critical for ensuring safety and achieving precise, regulatory-compliant LPS quantification.
Creative Biolabs has been committed to the development of endotoxin testing for many years. We employ sensitive, accurate, and rapid methods for endotoxin detection. We customize the most suitable assay for each project and use an assay or a combination of several assays to meet your requirements.
The LAL assay is a standard method for endotoxin detection of medical devices and parenteral drugs.
Learn More →The biosensor technique is a kind of modern endotoxin detection method which will eventually replace the gold standard of RPT and LAL tests.
Learn More →The rFC assay, an endotoxin sensitive synthetic protein, is cloned from factor C DNA to use as an alternative in vitro LAL test.
Learn More →The monocyte activation test allows the detection of the full range of pyrogens including endotoxins and non-endotoxin pyrogens to use as a human alternative in vitro RPT.
Learn More →Contact our expert team today to discuss a customized endotoxin detection strategy for your specific product matrix and regulatory requirements.
Our endotoxin detection service uses a rigorous, phase-gated workflow to select the ideal assay and customize sample preparation, ensuring accurate quantification and preventing masking in complex matrices.
Our commitment to lead generation is rooted in our ability to customize:
We offer customized assay selection or combination (LAL, rFC, MAT) based on product type and matrix complexity, ensuring optimal sensitivity and a lower risk of false results for complex biologics.
We perform full inhibition/enhancement testing and Method Validation strictly according to pharmacopeial standards, ensuring seamless regulatory submission and audit readiness.
Where applicable, we incorporate biosensor techniques for ultra-rapid and highly sensitive screening, leading to accelerated quality assurance timelines and faster batch release.
Our operations are backed by a certified quality management system across all testing procedures, providing absolute confidence in data integrity and operational reliability.
Partner with Creative Biolabs to leverage our deep scientific knowledge, state-of-the-art platforms, and commitment to compliance.
The Rfc assay uses a synthetic, chemically-defined protein, ensuring unparalleled batch-to-batch consistency and high stability. This eliminates biological variability, providing cleaner and more reproducible quantitative data required for rigorous QC.
Absolutely. We specialize in method suitability testing, which involves developing proprietary buffer systems and dilution protocols to neutralize inhibitory or enhancing components in your matrix. Our goal is to ensure a validated method with a spike recovery of 50%–200%.
Yes, MAT is the globally accepted in vitro alternative to RPT and is scientifically superior. It detects the full spectrum of pyrogens by measuring human cytokine release, providing a result highly relevant to human physiology.
Creative Biolabs offers complementary services essential for achieving comprehensive product purity and safety goals, from early development through batch release.
Creative Biolabs' systems leverage genetic immunization and recombinant protein technology to produce high-quality antibodies and proteins against previously intractable targets, advancing immuno-oncology and structural biology.
Learn More →Creative Biolabs offers antibody affinity maturation service using phage display (via random mutagenesis and stringent selection) and computational methods to enhance antibody/fragment/peptide binding affinity.
Learn More →Creative Biolabs offers the industry's most robust and flexible suite of endotoxin detection services, combining pharmacopeial compliance (LAL), cutting-edge specificity (rFC), and comprehensive pyrogen screening (MAT). We guarantee precise and validated results, enabling you to accelerate your therapeutic development with absolute confidence in product safety.
Contact Our Team for More Information and to Discuss Your Project